Kimberly Dequattro, MD
Rheumatology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Hospital of Univ of Pennsylvania · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Dequattro’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Hospital of Univ of PennsylvaniaPhiladelphia, PAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of University of Pennsylvania Health System, which runs 9 hospitals in 2 statesHome of Abramson Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 0.66 (0.51 to 0.81), Jul 2022 – Jun 2024Better than the national rate — Postoperative acute kidney injury requiring dialysis rate: 0.79 (0.04 to 1.54) · 4,129 cases, Jul 2022 – Jun 2024Better than the national rate — Postoperative respiratory failure rate: 4.02 (1.65 to 6.39) · 3,737 cases, Jul 2022 – Jun 2024Better than the national rate — Pressure ulcer rate: 0.25 (0 to 0.57) · 14,934 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.387, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.528, Oct 2024 – Sep 2025Better than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 3.6 (3 to 4.3) · 2,803 cases, Jan 2024 – Dec 2024Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,133 cases, Jan 2024 – Dec 2024
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Hospital of Univ of Pennsylvania
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 2 better, 4 the same, 1 worse of 7 measures. Readmissions: 2 better, 7 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.66 (0.51 to 0.81) | Better | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.79 (0.04 to 1.54) · 4,129 cases | Better | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.02 (1.65 to 6.39) · 3,737 cases | Better | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.25 (0 to 0.57) · 14,934 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.387 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.528 | Better | Oct 2024 – Sep 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 3.6 (3 to 4.3) · 2,803 cases | Better | Jan 2024 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,133 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.65 (0.02 to 1.28) · 4,557 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 179.18 (149.49 to 208.87) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.4 · 272 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 5.8 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.7 · 494 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 7.7 · 310 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.8 · 528 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2 · 5,552 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.09 to 0.4) · 14,207 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.13 to 0.45) · 16,673 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.22 (1.9 to 4.54) · 4,618 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.81 (1.94 to 3.69) · 5,517 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.16 (2.12 to 6.2) · 2,481 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.48 (0.36 to 2.59) · 1,920 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.984 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.891 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.144 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.091 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14 · 238 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.7 · 1,025 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 27.6 · 157 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.5 · 623 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.4 · 339 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.5 · 519 cases | None | Jul 2023 – Jun 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.4 (9.3 to 11.7) · 2,803 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 9.3 · 233 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21 · 342 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.5 (9.3 to 14.2) · 4,438 cases | No different | Jan 2022 – Dec 2024 |
What patients said (689 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 84% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 90% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 88% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 79% |
| Nurses "always" listened carefully | 84% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 61% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$18,740
Medicare paid this office $18,740 for 95 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 32 | $5,592 | $112 |
| Long return visit (40+ min) | 22 | $3,728 | $107 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,155 | $105 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 41 | $944 | $13 |
| Return visit (30+ min) | 11 | $838 | $76 |
See all 7 services
| Long return visit (40+ min) | 32 | $5,592 | $112 |
| Long return visit (40+ min) | 22 | $3,728 | $107 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,155 | $105 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 41 | $944 | $13 |
| Return visit (30+ min) | 11 | $838 | $76 |
| Return visit (30+ min) | 13 | $751 | $58 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 21 | $377 | $12 |
Who their Medicare patients are
95 Original Medicare patients in 2024. Average age 65 · Under 65 30% · Women 79% · Also on Medicaid 25% · Health risk score 2.00. Sicker patients than 9 in 10 peers; the typical rheumatology clinician is at 1.38.
Conditions among them: High blood pressure 71% · Chronic kidney disease 41% · Coronary heart disease 32% · Heart failure 25% · Cancer 25% · Depression 25% · Diabetes 23% · Atrial fibrillation 23% · COPD 18% · Stroke 13%.
The office billed $57,626, Medicare allowed $25,073 and paid $18,740; for 286 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 95 | 286 | 65 | 2.00 | $57,626 | $18,740 |
| 2023 | 92 | 209 | 65 | 2.23 | $55,868 | $20,066 |
| 2022 | 77 | 162 | 65 | 1.72 | $38,040 | $18,122 |
| 2021 | 68 | 121 | 63 | 1.58 | $33,243 | $9,209 |
| 2020 | 51 | 59 | 61 | 1.92 | $20,083 | $3,538 |
| 2019 | 26 | 41 | 66 | 1.93 | $30,345 | $3,472 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Long return visit (40+ min) | 30 | $5,814 | $106 |
| Long return visit (40+ min) | 33 | $5,769 | $111 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,642 | $63 |
| Return visit (30+ min) | 16 | $1,241 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,093 | $99 |
2022: 4 services
| Long return visit (40+ min) | 29 | $6,061 | $119 |
| Long return visit (40+ min) | 29 | $4,697 | $109 |
| New patient visit (60+ min) | 19 | $2,662 | $140 |
| New patient visit (60+ min) | 11 | $1,713 | $156 |
2021: 2 services
| Return visit (30+ min) | 17 | $1,637 | $78 |
| Telephone medical discussion with physician, 21-30 minutes | 22 | $1,496 | $52 |
2020: 3 services
| Long return visit (40+ min) | 15 | $1,159 | $77 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $933 | $72 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $418 | $35 |
2019: 1 service
| Long return visit (40+ min) | 18 | $1,969 | $90 |
Medicaid work
$12,334 in 2024
Medicaid paid $12,334 for 240 billed services this clinician did in 2024, up to 24 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 122 | $11,283 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 118 | $1,051 |
| 2024 | 240 | 2 | 24 | $12,334 |
| 2023 | 191 | 3 | 24 | $16,594 |
| 2022 | 101 | 3 | 15 | $8,545 |
| 2021 | 85 | 2 | 17 | $13,890 |
| 2020 | 12 | 1 | 12 | $2,732 |
See the largest Medicaid services in earlier years
2023
| Long return visit (40+ min) | 167 | $15,488 |
| Return visit (30+ min) | 12 | $1,034 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 12 | $72 |
2022
| Long return visit (40+ min) | 70 | $6,193 |
| New patient visit (60+ min) | 13 | $2,304 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 18 | $48 |
2021
| Clinic visit/encounter, all-inclusive | 55 | $12,330 |
| Return visit (30+ min) | 30 | $1,560 |
2020
| Clinic visit/encounter, all-inclusive | 12 | $2,732 |
Drugs they prescribed that Part D paid
$757,926
Pharmacies billed $757,926 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 656) in 2024. At or below the middle of the specialty; the typical rheumatology clinician is at 3%.
517 generic and 139 brand-name prescriptions · $757,926 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Benlysta | 33 | $150,578 | $4,563 |
| Cyltezo(Cf) | 13 | $81,486 | $6,268 |
| Mycophenolic Acid | 18 | $9,107 | $506 |
| Otrexup | 11 | $8,172 | $743 |
| Hydroxychloroquine Sulfate | 94 | $4,957 | $53 |
See all 17 drugs
| Benlysta | 33 | $150,578 | $4,563 |
| Cyltezo(Cf) | 13 | $81,486 | $6,268 |
| Mycophenolic Acid | 18 | $9,107 | $506 |
| Otrexup | 11 | $8,172 | $743 |
| Hydroxychloroquine Sulfate | 94 | $4,957 | $53 |
| Cevimeline | 13 | $4,603 | $354 |
| Methotrexate | 54 | $1,412 | $26 |
| Diclofenac | 20 | $748 | $37 |
| Mycophenolate Mofetil | 12 | $571 | $48 |
| Celecoxib | 24 | $543 | $23 |
| Leflunomide | 22 | $527 | $24 |
| Colchicine | 15 | $358 | $24 |
| Prednisone | 70 | $356 | $5 |
| Allopurinol | 32 | $355 | $11 |
| Entecavir | 14 | $312 | $22 |
| Alendronate | 14 | $265 | $19 |
| Gabapentin | 14 | $201 | $14 |
Year by year
| 2024 | 656 | 111 | 0% (0) | 21% | $757,926 |
| 2023 | 619 | 124 | None | 22% | $920,240 |
| 2022 | 408 | 96 | 0% (0) | 27% | $690,654 |
| 2021 | 358 | 69 | None | 22% | $367,517 |
| 2020 | 128 | 43 | 0% (0) | 25% | $116,210 |
| 2019 | 129 | 19 | None | 45% | $367,072 |
| 2018 | 31 | None | 0% (0) | 48% | $28,554 |
| 2017 | 83 | 13 | 0% (0) | 25% | $37,270 |
| 2016 | 246 | 23 | None | 10% | $106,717 |
| 2015 | 142 | 18 | None | None | $48,908 |
| 2014 | 54 | None | 0% (0) | 31% | $3,064 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Enbrel Sureclick | 26 | $184,774 | $7,107 |
| Humira | 12 | $179,494 | $14,958 |
| Benlysta | 24 | $116,230 | $4,843 |
| Humira(Cf) | 11 | $81,491 | $7,408 |
| Otrexup | 17 | $13,349 | $785 |
| Hydroxychloroquine Sulfate | 76 | $5,476 | $72 |
| Leflunomide | 27 | $3,063 | $113 |
| Methotrexate | 47 | $2,076 | $44 |
| Azathioprine | 26 | $1,751 | $67 |
| Diclofenac | 41 | $1,678 | $41 |
| Colchicine | 12 | $1,401 | $117 |
| Prednisone | 71 | $891 | $13 |
| Celecoxib | 13 | $665 | $51 |
| Allopurinol | 27 | $499 | $18 |
| Alendronate | 13 | $176 | $14 |
2022: 10 drugs
| Enbrel Sureclick | 39 | $263,536 | $6,757 |
| Humira | 14 | $153,171 | $10,941 |
| Humira | 11 | $138,766 | $12,615 |
| Hydroxychloroquine Sulfate | 44 | $6,087 | $138 |
| Colchicine | 12 | $3,708 | $309 |
| Methotrexate | 34 | $1,308 | $38 |
| Diclofenac | 32 | $1,207 | $38 |
| Celecoxib | 15 | $986 | $66 |
| Prednisone | 51 | $708 | $14 |
| Allopurinol | 16 | $225 | $14 |
2021: 10 drugs
| Enbrel Sureclick | 21 | $144,589 | $6,885 |
| Xeljanz | 15 | $79,956 | $5,330 |
| Hydroxychloroquine Sulfate | 48 | $5,177 | $108 |
| Methotrexate | 50 | $4,716 | $94 |
| Leflunomide | 29 | $2,891 | $100 |
| Mycophenolate Mofetil | 11 | $1,018 | $93 |
| Diclofenac | 32 | $998 | $31 |
| Prednisone | 57 | $606 | $11 |
| Sulfasalazine | 11 | $571 | $52 |
| Naproxen | 11 | $146 | $13 |
2020: 3 drugs
| Enbrel Sureclick | 11 | $63,185 | $5,744 |
| Methotrexate | 16 | $1,238 | $77 |
| Prednisone | 23 | $246 | $11 |
2019: 4 drugs
| Ilaris | 11 | $188,967 | $17,179 |
| Enbrel Sureclick | 16 | $86,814 | $5,426 |
| Otrexup | 12 | $8,111 | $676 |
| Prednisone | 21 | $391 | $19 |
2017: 1 drug
| Prednisone | 25 | $205 | $8 |
2016: 7 drugs
| Tamsulosin | 13 | $1,203 | $93 |
| Atorvastatin | 13 | $358 | $28 |
| Carvedilol | 24 | $241 | $10 |
| Omeprazole | 25 | $217 | $9 |
| Losartan | 15 | $124 | $8 |
| Prednisone | 11 | $91 | $8 |
| Metformin | 12 | $77 | $6 |
2015: 2 drugs
| Atorvastatin | 12 | $227 | $19 |
| Omeprazole | 21 | $166 | $8 |
Money from drug and device companies
$5,776 in 2025
| 2025 | 1 | 6 | $5,315 | $5,776 |
| 2024 | 1 | 1 | None | $99 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Genentech USA | Gazyva | $5,776 | 6 payments
|
See all 6 published payments
| Genentech USA | Meals · 2025-04-26 | Gazyva | $70 |
| Genentech USA | Meals · 2025-04-26 | Gazyva | $57 |
| Genentech USA | Meals · 2025-04-26 | Gazyva | $72 |
| Genentech USA | Consulting · 2025-04-26 | Gazyva | $5,315 |
| Genentech USA | Meals · 2025-04-26 | Gazyva | $35 |
| Genentech USA | Travel · 2025-04-26 | Gazyva | $227 |
See earlier years (2024)
2024: $99
| Aurinia Pharma U.S. | Lupkynis | $99 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 85.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1295096873
- Licence
- PA MD474947
- Trained
- University of Southern California Keck School of Medicine, 2012
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RR0500X (207RR0500X); Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2012-05-31
- NPI last updated
- 2025-09-17
- NPI record certified
- 2025-09-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3400 Spruce Street, Philadelphia, PA, 19104